Search Orphan Drug Designations and Approvals
-
Generic Name: | Multicyclic 2-aminothiazole carboxamide that inhibits tubulin polymerization |
---|---|
Date Designated: | 10/31/2023 |
Orphan Designation: | Treatment of Glioblastoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Reglagene, Inc. 3320 N Campbell Ave, Suite 200 Tucson, Arizona 85719 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-